scholarly article | Q13442814 |
P356 | DOI | 10.1111/J.1399-0012.2009.01070.X |
P698 | PubMed publication ID | 19719728 |
P50 | author | Hans Sollinger | Q89951480 |
P2093 | author name string | R Shapiro | |
B D Kahan | |||
P R Rajagopalan | |||
M I Lorber | |||
H Mayer | |||
C E Foster | |||
D B Carvalho | |||
FTY720A2202 clinical study group | |||
H Tedesco-Silva | |||
J Slade | |||
R Mendez | |||
P2860 | cites work | Cell type-specific localization of human cardiac S1P receptors | Q28215436 |
Early, abrupt conversion of de novo renal transplant patients from cyclosporine to everolimus: results of a pilot study | Q46750522 | ||
FTY720 immunosuppression impairs effector T cell peripheral homing without affecting induction, expansion, and memory. | Q52026935 | ||
P433 | issue | 5 | |
P921 | main subject | multicenter clinical trial | Q6934595 |
P304 | page(s) | 589-599 | |
P577 | publication date | 2009-08-27 | |
P1433 | published in | Clinical Transplantation | Q15754920 |
P1476 | title | FTY720 and everolimus in de novo renal transplant patients at risk for delayed graft function: results of an exploratory one-yr multicenter study | |
P478 | volume | 23 |
Q35953902 | A systematic evaluation of the safety and toxicity of fingolimod for its potential use in the treatment of acute myeloid leukaemia. |
Q36861092 | Effect of FTY720 (fingolimod) on graft survival in renal transplant recipients: a systematic review protocol. |
Q83973683 | Effects of long-term administration of low-dose FTY720 on survival of murine cardiac allograft |
Q37945385 | Fifty years in the vineyard of transplantation: looking back |
Q26785848 | Lymphatic disorders after renal transplantation: new insights for an old complication |
Q21296721 | Sphingolipids: a potential molecular approach to treat allergic inflammation |
Q37813491 | Sphingosine-1-phosphate: a potential therapeutic target for rheumatoid arthritis |
Q37888772 | The emerging role of Brazil in clinical trial conduct for transplantation |
Q84744062 | The sphingosine-1-phosphate receptor agonist FTY720 prevents the development of anti-glomerular basement membrane glomerulonephritis |
Search more.